Literature DB >> 16084883

Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters.

Enrico Carmina1, Francesco Orio, Stefano Palomba, Rosa A Longo, Gaetano Lombardi, Rogerio A Lobo.   

Abstract

OBJECTIVE: To determine how common polycystic ovarian morphology may be in women given the clinical diagnosis of polycystic ovary syndrome (PCOS) based on chronic anovulation and hyperandrogenism and whether certain hormonal factors correlate with ovarian morphology and blood flow.
DESIGN: Prospective study.
SETTING: Two academic endocrinology centers in Italy. PATIENT(S): Three hundred twenty-six women with PCOS and 50 age-matched and weight-matched ovulatory women. INTERVENTION(S): Ultrasound assessment of ovarian morphology in patients and controls and ovarian blood flow and fasting hormone levels in a subset of 50 patients and matched controls. MAIN OUTCOME MEASURE(S): Ovarian morphological assessments, ovarian blood flow by pulsatility index (PI) and resistance index (RI), and measurements of gonadotropins, estrogen, sex hormone-binding globulin, androgens, inhibin B, glucose, and insulin. RESULT(S): Using strict ultrasound criteria, 195 woman (60%) had enlarged ovaries, 135 (35%) had normal ovarian size but characteristic morphology, and 16 (5%) had normal size and morphology. Ovarian blood flow was increased (reduced PI and RI) in PCOS. All hormonal parameters were elevated in PCOS. Ovarian size correlated only with insulin and a measure of insulin resistance. Ovarian blood flow correlated positively with insulin, T, free T, and E2 but not with luteinizing hormone. Inhibin B showed a negative correlation with ovarian blood flow. CONCLUSION(S): When a clinical diagnosis of PCOS was made, virtually all women were found to have characteristic ovarian morphology. Insulin correlated with increased ovarian size as well as with increased blood flow. Blood flow also correlated positively with sex steroids but negatively with inhibin B.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16084883     DOI: 10.1016/j.fertnstert.2004.12.061

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  17 in total

1.  Assessing cardiovascular risk in Mediterranean women with polycystic ovary syndrome.

Authors:  M Rizzo; R A Longo; E Guastella; G B Rini; E Carmina
Journal:  J Endocrinol Invest       Date:  2010-10-15       Impact factor: 4.256

2.  Bariatric Surgery Improves Hyperandrogenism, Menstrual Irregularities, and Metabolic Dysfunction Among Women with Polycystic Ovary Syndrome (PCOS).

Authors:  Jacob P Christ; Tommaso Falcone
Journal:  Obes Surg       Date:  2018-08       Impact factor: 4.129

3.  Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin.

Authors:  Angela Falbo; Morena Rocca; Tiziana Russo; Antonietta D'Ettore; Achille Tolino; Fulvio Zullo; Francesco Orio; Stefano Palomba
Journal:  J Ovarian Res       Date:  2010-07-21       Impact factor: 4.234

Review 4.  Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies.

Authors:  Marla E Lujan; Donna R Chizen; Roger A Pierson
Journal:  J Obstet Gynaecol Can       Date:  2008-08

5.  Prevalence and metabolic characteristics of adrenal androgen excess in hyperandrogenic women with different phenotypes.

Authors:  E Carmina; R A Lobo
Journal:  J Endocrinol Invest       Date:  2007-02       Impact factor: 4.256

6.  Evaluation of endocrine changes in women with the polycystic ovary syndrome during metformin treatment.

Authors:  Zelija Velija-Ašimi
Journal:  Bosn J Basic Med Sci       Date:  2013-08       Impact factor: 3.363

7.  The prevalence of metabolic syndrome and insulin resistance according to the phenotypic subgroups of polycystic ovary syndrome in a representative sample of Iranian females.

Authors:  Ferdous Mehrabian; Behnaz Khani; Roya Kelishadi; Narges Kermani
Journal:  J Res Med Sci       Date:  2011-06       Impact factor: 1.852

8.  Single nucleotide polymorphisms in binding site of miRNA-135a and targeted gene IRS2 are correlated with multiple clinical features of PCOS: A study in Chinese women.

Authors:  Heng Gu; Longyu Li; Bingyi Zhou; Mingzhen Li; Wenyao Zhong; Xiangcai Wei; Xingmin Zhong
Journal:  Technol Health Care       Date:  2022       Impact factor: 1.205

9.  Does metformin affect ovarian morphology in patients with polycystic ovary syndrome? A retrospective cross-sectional preliminary analysis.

Authors:  Angela Falbo; Francesco Orio; Roberta Venturella; Erika Rania; Caterina Materazzo; Achille Tolino; Fulvio Zullo; Stefano Palomba
Journal:  J Ovarian Res       Date:  2009-05-31       Impact factor: 4.234

10.  Characterization of ovarian development in girls from birth to 9 months.

Authors:  Helen B Chin; Donna D Baird; Summer L Kaplan; Kassa Darge; Margaret A Adgent; Eileen G Ford; Walter J Rogan; Virginia A Stallings; David M Umbach
Journal:  Paediatr Perinat Epidemiol       Date:  2020-04-13       Impact factor: 3.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.